Dapsone‐Induced Methemoglobinemia After Accidental Dose Duplication in a Patient Receiving Long‐Term Therapy: A Case Report
Clinical Case Reports · 2026-11 · 14 (11)
DOI: 10.1002/ccr3.73533 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 19.11.2026. Verfasst von Hamzeh Alsaleh und 6 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamad Medical Corporation.
Abstract (Originalsprache)
Dapsone is a synthetic sulfone antibiotic with immunosuppressive properties that is widely used for the treatment of dermatological and infectious diseases. Dapsone‐induced methemoglobinemia (DIM) has been reported in literature upon chronic and acute exposure to dapsone. By reporting this case, we aim to provide valuable insight into the existing literature by elucidating the dose–response relationship in DIM. This is a case of a nineteen‐year‐old female patient who presented to our emergency department (ED) complaining of shortness of breath (SOB) and palpitations for one day. Emergency medical services paramedics found her to be desaturating at 84% on pulse oximetry. Initial testing revealed metabolic acidosis with a methemoglobin concentration of 21% and hemoglobin of 9.8 g/dL. She reported accidental ingestion of double her daily dapsone dose of 100 mg, which she had been taking for the past year for subcorneal pustular dermatosis. A diagnosis of dapsone‐induced methemoglobinemia (DIM) was confirmed. Optimal treatments and supportive management were provided, and the patient was discharged 36 h later. Dapsone is a sulfone antibiotic that also has immunosuppressive effects. It is commonly used to treat a range of dermatological conditions and infectious diseases. Its dual antimicrobial and anti‐inflammatory actions make it valuable in both infectious and immune‐mediated skin disorders. Dapsone has been associated with the development of methemoglobinemia, a potentially life‐threatening condition characterized by elevated levels of methemoglobin in the blood. Methemoglobinemia arises when the iron moiety within hemoglobin is oxidized from the ferrous (Fe 2+ ) to the ferric (Fe 3+ ) state, thus impairing oxygen‐carrying capacity. Unlike most cases of DIM, which are associated with the prolonged use of therapeutic doses or the acute excessive consumption of dapsone, this unique case involves acute toxicity from a single accidental dose duplication. Therefore, our case explores the susceptibility to acute toxicity with a single additional dose of dapsone in a patient with prolonged exposure to it. This case adds to the existing literature on dapsone‐induced methemoglobinemia and highlights the possibility of clinically significant toxicity following a single accidental dose duplication in a patient receiving long‐term dapsone therapy.
Förderung
- Hamad Medical Corporation
Zitieren
APA
Alsaleh, H., Khan, A., Javid, S., Awadelseed, S., Alfawares, R., Hamdeh, H., & Mohamed, A. (2026). Dapsone‐Induced Methemoglobinemia After Accidental Dose Duplication in a Patient Receiving Long‐Term Therapy: A Case Report. Clinical Case Reports, 14(11). https://doi.org/10.1002/ccr3.73533
Vancouver
Alsaleh H, Khan A, Javid S, Awadelseed S, Alfawares R, Hamdeh H, et al. Dapsone‐Induced Methemoglobinemia After Accidental Dose Duplication in a Patient Receiving Long‐Term Therapy: A Case Report. Clinical Case Reports. 2026;14(11). doi:10.1002/ccr3.73533
BibTeX
@article{Alsaleh2026,
author = {Alsaleh, Hamzeh and Khan, Aisha and Javid, Sasha and Awadelseed, Sujood and Alfawares, Reem and Hamdeh, Homam and Mohamed, Asmaa},
title = {Dapsone‐Induced Methemoglobinemia After Accidental Dose Duplication in a Patient Receiving Long‐Term Therapy: A Case Report},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/ccr3.73533}
}
EUVIMED